These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8584730

  • 1. [Gene therapy for cardiovascular disease].
    Morishita R, Ogihara T, Keneda Y.
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2739-45. PubMed ID: 8584730
    [No Abstract] [Full Text] [Related]

  • 2. Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Trans Assoc Am Physicians; 1993 Dec; 106():54-61. PubMed ID: 8036745
    [No Abstract] [Full Text] [Related]

  • 3. [Gene therapy concepts in coronary stenoses].
    Schott E, Paul M.
    Internist (Berl); 1996 Apr; 37(4):350-9. PubMed ID: 8655271
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of intimal hyperplasia by gene therapy: an update].
    Reis E, Martinet O, Mosimann F.
    J Mal Vasc; 1999 Dec; 24(5):349-55. PubMed ID: 10642646
    [Abstract] [Full Text] [Related]

  • 5. [Gene therapy for restenosis after angioplasty].
    Morishita R, Higaki J, Ogihara T.
    Rinsho Byori; 1997 Feb; Suppl 104():224-31. PubMed ID: 9128386
    [No Abstract] [Full Text] [Related]

  • 6. [Concepts for local therapy of restenosis].
    Riessen R, Oberhoff M, Karsch KR.
    Z Kardiol; 1996 Feb; 85 Suppl 1():87-98. PubMed ID: 8882829
    [Abstract] [Full Text] [Related]

  • 7. [Restenosis after angioplasty. Clinical significance, pathobiology, future developments for suppression of recurrent stenoses].
    Höfling B, Gonschior P, Esin S, Nikol S.
    Internist (Berl); 1997 Jan; 38(1):31-43. PubMed ID: 9119657
    [No Abstract] [Full Text] [Related]

  • 8. [Development of in vivo gene transfer methods towards future gene therapy].
    Kaneda Y, Morishita R.
    Rinsho Byori; 1997 Feb; 45(2):99-105. PubMed ID: 9121006
    [Abstract] [Full Text] [Related]

  • 9. Post-intervention vessel remodeling.
    Rutanen J, Puhakka H, Ylä-Herttuala S.
    Gene Ther; 2002 Nov; 9(22):1487-91. PubMed ID: 12407420
    [Abstract] [Full Text] [Related]

  • 10. Prospects for gene therapy of postangioplasty restenosis.
    Steg PG, Feldman LJ.
    Adv Nephrol Necker Hosp; 1997 Nov; 26():121-31. PubMed ID: 8922129
    [No Abstract] [Full Text] [Related]

  • 11. [Gene therapy of restenosis].
    Steg PG, Feldman L.
    Pathol Biol (Paris); 1998 Mar; 46(3):201-4. PubMed ID: 9769916
    [Abstract] [Full Text] [Related]

  • 12. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans.
    Circulation; 1997 Aug 19; 96(4):1067-8. PubMed ID: 9286927
    [No Abstract] [Full Text] [Related]

  • 13. Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
    von der Leyen HE, Mann MJ, Dzau VJ.
    Semin Interv Cardiol; 1996 Sep 19; 1(3):209-14. PubMed ID: 9552513
    [Abstract] [Full Text] [Related]

  • 14. Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation.
    Nikol S, Huehns TY, Krausz E, Armeanu S, Engelmann MG, Winder D, Salmons B, Hoefling B.
    Gene Ther; 1999 May 19; 6(5):737-48. PubMed ID: 10505096
    [Abstract] [Full Text] [Related]

  • 15. [Alternative techniques in coronary intervention--a new differential therapy?].
    Kober G.
    Z Kardiol; 1996 May 19; 85 Suppl 1():1-7. PubMed ID: 8882818
    [Abstract] [Full Text] [Related]

  • 16. [Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting].
    Bernardi G.
    Ital Heart J Suppl; 2001 May 19; 2(5):559-62. PubMed ID: 11388337
    [No Abstract] [Full Text] [Related]

  • 17. [Intracoronary brachytherapy against restenosis after percutaneous transluminal coronary angioplasty].
    Holm AM, Haunsø S, Hansen PR.
    Ugeskr Laeger; 1999 Feb 08; 161(6):802. PubMed ID: 10028887
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical strategies for development of intracoronary stents].
    Dong W, Li J, Li F.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Jun 08; 14(2):156-63. PubMed ID: 9817646
    [Abstract] [Full Text] [Related]

  • 19. [I/D polymorphism of the ACE gene and A1166C of the AT1R gene as risk factors for restenosis after coronary angioplasty].
    Gensini F, Battaglini B, Fatini C, Guazzelli R, Falai M, Chioccioli M, Simonetti I, Comeglio M, Giglioli C, Martinucci P, Gensini GF.
    Minerva Cardioangiol; 1999 Dec 08; 47(12):516. PubMed ID: 10670180
    [No Abstract] [Full Text] [Related]

  • 20. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM, Haunsø S, Hansen PR.
    Ugeskr Laeger; 1998 Feb 23; 160(9):1302-6. PubMed ID: 9495077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.